SAMANDARIDINE
UNII WCB49WL3GW

Substance Identification & Data

This profile provides standardized clinical and technical data for Samandaridine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WCB49WL3GW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 6384-73-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WCB49WL3GW

CAS Registry Number

6384-73-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SAMANDARIDINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C21H31NO3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

GUSZSGSYIVZEDM-MZDLDJOOSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

165454

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C[C@@]12[C@]([C@]3([C@@]([C@]4(C)[C@](CC3)(C[C@@H]5O[C@H]4CN5)[H])(CC1)[H])[H])(C[C@]6([C@@]2(CC(=O)O6)[H])[H])[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Samandaridine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

SAMANDARIDIN

SAMANDARIDINE

Systematic Nomenclature

(2S,5R,5AS,5BS,7AS,7BR,10AS,11AS,11BS,13AR)-OCTADECAHYDRO-5A,7A-DIMETHYL-2,5-EPOXYFURO(3,2:3,4)CYCLOPENTA(1,2:5,6)NAPHTH(1,2-D)AZEPIN-9(1H)-ONE

SYS

2,5-EPOXYFURO(3,2:3,4)CYCLOPENTA(1,2:5,6)NAPHTH(1,2-D)AZEPIN-9(1H)-ONE, OCTADECAHYDRO-5A,7A-DIMETHYL-, (2S-(2.ALPHA.,5.ALPHA.,5A.BETA.,5B.ALPHA.,7A.BETA.,7B.ALPHA.,10A.ALPHA.,11A.ALPHA.,11B.BETA.,13A.BETA.))-

SYS

2,5-EPOXYFURO(3,2:3,4)CYCLOPENTA(1,2:5,6)NAPHTH(1,2-D)AZEPIN-9(1H)-ONE, OCTADECAHYDRO-5A,7A-DIMETHYL-, (2S,5R,5AS,5BS,7AS,7BR,10AS,11AS,11BS,13AR)-

SYS

3-AZA-A-HOMOPREGNAN-21-OIC ACID, 1,4-EPOXY-16-HYDROXY-, .GAMMA.-LACTONE, (1.ALPHA.,4.ALPHA.,5.BETA.,16.BETA.)-

SYS